mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-05 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.18 |
9e-05 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0001 |